Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis
2014-004558-33Phase 3
- Sponsor
- Abbott Laboratories
- Start
- Dec 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in polyarticular juvenile idiopathic arthritis and rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Primary endpoint: PedACR30 response at Week 16.
02
Drugs
03
Conditions
polyarticular juvenile idiopathic arthritisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2014-004558-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004558-33.